Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Beijing Tongrentang Co., Ltd.    600085   CNE000000R69

BEIJING TONGRENTANG CO., LTD.

(600085)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
07/15/2019 07/16/2019 07/17/2019 07/18/2019 07/19/2019 Date
29.79(c) 29.32(c) 29.11(c) 28.96(c) 28.87 Last
5 577 451 3 734 897 4 733 932 2 846 138 3 688 767 Volume
-0.77% -1.58% -0.72% -0.52% -0.31% Change
More quotes
Financials (CNY)
Sales 2019 15 433 M
EBIT 2019 2 432 M
Net income 2019 1 187 M
Finance 2019 6 411 M
Yield 2019 1,54%
Sales 2020 16 821 M
EBIT 2020 2 578 M
Net income 2020 1 287 M
Finance 2020 7 285 M
Yield 2020 1,26%
P/E ratio 2019 33,5x
P/E ratio 2020 30,9x
EV / Sales2019 2,15x
EV / Sales2020 1,92x
Capitalization 39 594 M
More Financials
Company
BEIJING TONGRENTANG CO., LTD is a China-based company principally engaged in the production and sales of traditional Chinese patent medicines. The Company’s main products consist of liuwei dihuang series, tongren dahuoluo series, tongren niuhuang qingxin series, angong niuhuang series and... 
Sector
Pharmaceuticals
Calendar
08/27Earnings Release
More about the company
Surperformance© ratings of Beijing Tongrentang Co., L
Trading Rating : Investor Rating :
More Ratings
Latest news on BEIJING TONGRENTANG CO., L
03/28As China pushes traditional medicine globally, illegal wildlife trade flouris..
RE
03/21BEIJING TONGRENTANG CO., LTD. : annual earnings release
2013CORRECTED-From street stalls to bourses, SE Asia's traditional medicine maker..
RE
More news
Analyst Recommendations on BEIJING TONGRENTANG CO., L
More recommendations
Sector news : Alternative Medicine
07/19CELGENE : Says FDA Approves Otezla for Oral Ulcers in Behcet's Disease
DJ
07/19ALLERGAN : Form 8.3 -
DJ
07/19Gilead Licenses Respiratory, Herpes Antiviral Research Programs From Novartis
DJ
07/19JOHNSON & JOHNSON : J&J's Janssen Seeks Europe OK For Subcutaneous Darzalex in M..
DJ
07/19BAYER : Syngenta profits hit by U.S./China trade wars, bad weather
RE
More sector news : Alternative Medicine
Chart BEIJING TONGRENTANG CO., LTD.
Duration : Period :
Beijing Tongrentang Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BEIJING TONGRENTANG CO., L
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 35,68  CNY
Last Close Price 28,87  CNY
Spread / Highest target 54,8%
Spread / Average Target 23,6%
Spread / Lowest Target -16,9%
EPS Revisions
Managers
NameTitle
Xiang Guang Liu General Manager & Director
Zhen Kun Gao Chairman
Bao Jian Ma Chairman-Supervisory Board
Hai Ou Gu Director
Zhi Mei Feng Director & Chief Accountant
Sector and Competitors
1st jan.Capitalization (M$)
BEIJING TONGRENTANG CO., LTD.5.31%5 756
CANOPY GROWTH CORP27.31%12 249
AURORA CANNABIS INC33.48%6 936
CRONOS GROUP INC35.33%5 018
DONG-E-E-JIAO CO LTD--.--%3 122
APHRIA INC0.00%1 608